Automation – Electronic Batch Management (EBM) Manager
Takeda
Summary
Baxalta US Inc. is seeking an Automation – Electronic Batch Management (EBM) Manager to manage and coordinate the EBM team, initiatives, and projects using the Siemens Op Center Platform (Siemens XFP / Manufacturing Execution System Platform).
Job description
Position Description
Baxalta US Inc. is seeking an Automation – Electronic Batch Management (EBM) Manager to manage and coordinate the EBM team, initiatives, and projects using the Siemens Op Center Platform (Siemens XFP / Manufacturing Execution System Platform).
- Make suggestions on improvements based on supporting data, technical knowledge, engineering principles, and current industry practices
- Manage or support EBM activities for capital project scope definition, budget, schedule, and resource allocation
- Lead, plan, coordinate execution and implementation of activities to maintain, enhance, and develop process instructions and script libraries in the Siemens EBR system (MES)
- Manage and control spending of approved operational and capital automation project funds
- Drive projects to completion within timeline and budget objectives
- Create or update technical support specifications (Design/Functional/System) related to project assignments
- Integrate third-party systems, ERP, and control systems applications (such as JDE and Emerson DeltaV)
- Supervise contractors and junior-level engineering personnel on project and operational support activities
- Provide EBM operational support including monitoring system performance and addressing system or application issues impacting production areas
- Demonstrate continuous improvement in job knowledge and proficiency related to engineering in the biopharmaceutical industry
- Design and implement changes to EBM or automation systems while adhering to pharmaceutical validation and change control systems
- Perform event investigations related to EBM automation systems and implement corrective and preventative actions
- Perform and document hardware/software modifications and system functional specification updates
- Prepare standard operating procedures for new and existing control equipment
Requirements
- Bachelor's degree in Engineering or related field
- 8 years of relevant work experience
- 10 years of experience analyzing production workflows to configure and implement MES modules for real-time monitoring of manufacturing operations
- 5 years of experience implementing batch recipe management within EBM systems
- 8 years of experience planning project timelines and resource allocation using project management tools
- 8 years of experience coordinating cross-functional teams to execute system deployment activities within defined scope, schedule, and budget
Benefits
- Medical, Dental & Vision
- 401(k)
- Paid Time Off
- Sick Leave
- Company Holidays
- Incentive Compensation Programs
Company overview
Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.